Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Strohbehn, GW"'
Autor:
Shankar-Hari, M, Vale, CL, Godolphin, PJ, Fisher, D, Higgins, JPT, Spiga, F, Savovic, J, Tierney, J, Baron, G, Benbenishty, JS, Berry, LR, Broman, N, Cavalcanti, AB, Colman, R, De Buyser, SL, Derde, LPG, Domingo, P, Omar, SF, Fernandez-Cruz, A, Feuth, T, Garcia, F, Garcia-Vicuna, R, Gonzalez-Alvaro, I, Gordon, AC, Haynes, R, Hermine, O, Horby, PW, Horick, NK, Kumar, K, Lambrecht, BN, Landray, MJ, Leal, L, Lederer, DJ, Lorenzi, E, Mariette, X, Merchante, N, Misnan, NA, Mohan, SV, Nivens, MC, Oksi, J, Perez-Molina, JA, Pizov, R, Porcher, R, Postma, S, Rajasuriar, R, Ramanan, AV, Ravaud, P, Reid, PD, Rutgers, A, Sancho-Lopez, A, Seto, TB, Sivapalasingam, S, Soin, AS, Staplin, N, Stone, JH, Strohbehn, GW, Sunden-Cullberg, J, Torre-Cisneros, J, Tsai, LW, van Hoogstraten, H, van Meerten, T, Veiga, VC, Westerweel, PE, Murthy, S, Diaz, JV, Marshall, JC, Sterne, JAC, Pomar V., Benito N., WHO Rapid Evidence Appraisal COVID
Publikováno v:
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
IMPORTANCE Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized for COVID-19 have variously reported benefit, no effect, and harm. OBJECTIVE To estimate the association between administration of IL-6 antagonists compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a2c5c0ab547ccf2be0501d4122d08556
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4406
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4406
Autor:
Tannock IF; Division of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada; Optimal Cancer Care Alliance, Ann Arbor, MI, USA. Electronic address: ian.tannock@uhn.ca., Buyse M; IDDI (International Drug Development Institute), Louvain-la-Neuve, Belgium; I-BioStat, Hasselt University, Hasselt, Belgium., De Backer M; IDDI (International Drug Development Institute), Louvain-la-Neuve, Belgium., Earl H; Department of Oncology, University of Cambridge, Cambridge, UK., Goldstein DA; Optimal Cancer Care Alliance, Ann Arbor, MI, USA; Davidoff Cancer Center, Rabin Medical Center, Israel; Clalit Health Services, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Ratain MJ; Optimal Cancer Care Alliance, Ann Arbor, MI, USA; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA., Saltz LB; Optimal Cancer Care Alliance, Ann Arbor, MI, USA; Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sonke GS; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Amsterdam, Netherlands; University of Amsterdam, Amsterdam, Netherlands., Strohbehn GW; Optimal Cancer Care Alliance, Ann Arbor, MI, USA; Veterans Affairs Center for Clinical Management Research, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA; Division of Oncology and Lung Precision Oncology Program, University of Michigan Division of Hematology/Oncology, Rogel Cancer Center, Institute for Health Policy and Innovation, and Center for Global Health Equity, Ann Arbor, MI, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Oct; Vol. 25 (10), pp. e520-e525.
Autor:
Strohbehn GW; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA.; Division of Medical Oncology, Lieutenant Colonel Charles S. Kettles VA Medical Center, Ann Arbor, MI, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.; Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, MI, USA., Stadler WM; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA., Boonstra PS; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA., Ratain MJ; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA.; Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA.; Center for Personalized Therapeutics, The University of Chicago, Chicago, IL, USA.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2024 Jun; Vol. 21 (3), pp. 340-349. Date of Electronic Publication: 2023 Dec 27.
Autor:
Bryant AK; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA; Department of Radiation Oncology, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA; Lung Precision Oncology Program, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Lewy JR; University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA., Bressler RD; School of International and Public Affairs, Columbia Climate School, and Center for Environmental Economics and Policy, Columbia University, New York, NY, USA., Chopra Z; University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; Department of Economics, University of Michigan, Ann Arbor, MI, USA., Gyori DJ; Division of Oncology, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA., Bazzell BG; Division of Oncology, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA., Moeller JA; Division of Oncology, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA., Jacobson SI; Yale College, New Haven, CT, USA., Fendrick AM; Division of General Internal Medicine, University of Michigan, Ann Arbor, MI, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA; Center for Value-Based Insurance Design, University of Michigan, Ann Arbor, MI, USA., Kerr EA; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA; Division of General Internal Medicine, University of Michigan, Ann Arbor, MI, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA., Ramnath N; Lung Precision Oncology Program, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA; Division of Oncology, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Green MD; Department of Radiation Oncology, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA; Lung Precision Oncology Program, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA; Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, USA., Hofer TP; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA; Division of General Internal Medicine, University of Michigan, Ann Arbor, MI, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA; Center for Global Health Equity, University of Michigan, Ann Arbor, MI, USA., Vaishnav P; School for Environment and Sustainability, University of Michigan, Ann Arbor, MI, USA., Strohbehn GW; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA; Lung Precision Oncology Program, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA; Division of Oncology, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA; Center for Global Health Equity, University of Michigan, Ann Arbor, MI, USA. Electronic address: gstrohbe@umich.edu.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Jun; Vol. 25 (6), pp. 802-810.
Autor:
Strohbehn GW; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA. gstrohbe@umich.edu.; Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA. gstrohbe@umich.edu.; Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, MI, USA. gstrohbe@umich.edu.; Center for Global Health Equity, University of Michigan, Ann Arbor, MI, USA. gstrohbe@umich.edu., Ratain MJ; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA.
Publikováno v:
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2024 May; Vol. 21 (5), pp. 331-332.
Autor:
Strohbehn GW; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA. gstrohbe@umich.edu.; Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA. gstrohbe@umich.edu.; Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, MI, USA. gstrohbe@umich.edu., Gyawali B; Department of Oncology, Division of Cancer Care and Epidemiology, Queen's University, Kingston, Ontario, Canada.
Publikováno v:
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2024 Apr; Vol. 21 (4), pp. 249-250.
Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer.
Autor:
Edwards DM; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan., Sankar K; Department of Medicine, Division of Medical Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Alseri A; Department of Radiology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan., Jiang R; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan., Schipper M; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan., Miller S; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan., Dess K; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan., Strohbehn GW; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan; Department of Medicine, Division of Hematology Oncology, University of Michigan, Ann Arbor, Michigan; Department of Medicine, Division of Hematology Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan; VA Center for Clinical Management Research, Ann Arbor, Michigan., Elliott DA; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan., Moghanaki D; Department of Radiation Oncology, UCLA Jonsson Cancer Center, Los Angeles, California; Department of Radiation Oncology, Veterans Affairs Los Angeles Healthcare System, Los Angeles, California., Ramnath N; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan; Department of Medicine, Division of Hematology Oncology, University of Michigan, Ann Arbor, Michigan; Department of Medicine, Division of Hematology Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan., Green MD; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan; Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan., Bryant AK; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan. Electronic address: bralex@med.umich.edu.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Mar 15; Vol. 118 (4), pp. 963-970. Date of Electronic Publication: 2023 Oct 02.
Autor:
Strohbehn GW; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA.; Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Ratain MJ; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Feb 08; Vol. 116 (2), pp. 177-179.
Autor:
Gyawali B; Department of Oncology, Queen's University, Kingston, Canada.; Department of Public Health Sciences, Queen's University, Kingston, Canada.; Division of Cancer Care and Epidemiology, Queen's University, Kingston, Canada., Strohbehn GW; Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Jan 01; Vol. 10 (1), pp. 41-42.
Autor:
Ratain MJ; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA. Electronic address: mratain@bsd.uchicago.edu., Strohbehn GW; Veterans Affairs Center for Clinical Management Research and Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Nov; Vol. 194, pp. 113349. Date of Electronic Publication: 2023 Sep 20.